Alzheimer-associated cerebrospinal fluid fragments of neurogranin are generated by Calpain-1 and prolyl endopeptidase
暂无分享,去创建一个
K. Blennow | H. Zetterberg | E. Portelius | G. Brinkmalm | M. Olsson | K. Höglund | Hlin Kvartsberg | Bruno Becker | F. Nazir | M. Kalm | M. Boström | E. Camporesi
[1] J. A. García-Horsman,et al. Mechanism of Action of Prolyl Oligopeptidase (PREP) in Degenerative Brain Diseases: Has Peptidase Activity Only a Modulatory Role on the Interactions of PREP with Proteins? , 2017, Front. Aging Neurosci..
[2] M. Morawski,et al. Deficiency of prolyl oligopeptidase in mice disturbs synaptic plasticity and reduces anxiety-like behaviour, body weight, and brain volume , 2016, European Neuropsychopharmacology.
[3] N. Gerges,et al. Neurogranin restores amyloid β-mediated synaptic transmission and long-term potentiation deficits , 2016, Experimental Neurology.
[4] Nick C Fox,et al. Increased CSF neurogranin concentration is specific to Alzheimer disease , 2016, Neurology.
[5] J. Rossignol,et al. Molecular regulation of dendritic spine dynamics and their potential impact on synaptic plasticity and neurological diseases , 2015, Neuroscience & Biobehavioral Reviews.
[6] K. Blennow,et al. Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease , 2015, Annals of clinical and translational neurology.
[7] M. Weiner,et al. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease. , 2015, Brain : a journal of neurology.
[8] K. Blennow,et al. Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease , 2015, Alzheimer's & Dementia.
[9] K. Blennow,et al. Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer’s disease patients and healthy controls , 2015, Alzheimer's Research & Therapy.
[10] K. Blennow,et al. Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease , 2010, Brain Research.
[11] A. Saghatelian,et al. Peptidomics of prolyl endopeptidase in the central nervous system. , 2009, Biochemistry.
[12] F. J. Díez-Guerra,et al. Activity-dependent translocation of neurogranin to neuronal nuclei. , 2009, The Biochemical journal.
[13] J. Tenorio-Laranga,et al. Issues About the Physiological Functions of Prolyl Oligopeptidase Based on Its Discordant Spatial Association With Substrates and Inconsistencies Among mRNA, Protein Levels, and Enzymatic Activity , 2009, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[14] Ling Zhong,et al. Neurogranin enhances synaptic strength through its interaction with calmodulin , 2009, The EMBO journal.
[15] W. Nickel,et al. Unconventional mechanisms of protein transport to the cell surface of eukaryotic cells. , 2008, Annual review of cell and developmental biology.
[16] Ming Liu,et al. Calpain in the CNS: From Synaptic Function to Neurotoxicity , 2008, Science Signaling.
[17] F. J. Díez-Guerra,et al. Neurogranin binds to phosphatidic acid and associates to cellular membranes. , 2007, The Biochemical journal.
[18] F. Schmitt,et al. Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment , 2006, Neurobiology of Aging.
[19] B. Devreese,et al. Search for substrates for prolyl oligopeptidase in porcine brain , 2005, Peptides.
[20] M. Frotscher,et al. Neurogranin is expressed by principal cells but not interneurons in the rodent and monkey neocortex and hippocampus , 2004, The Journal of comparative neurology.
[21] B. Gerhartz,et al. Modulation of inositol 1,4,5-triphosphate concentration by prolyl endopeptidase inhibition. , 2002, European journal of biochemistry.
[22] M. Bähler,et al. Calmodulin signaling via the IQ motif , 2002, FEBS letters.
[23] K. Reymann,et al. Involvement of neurogranin in the modulation of calcium/calmodulin-dependent protein kinase II, synaptic plasticity, and spatial learning: a study with knockout mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[24] G. Edelman,et al. Marking synaptic activity in dendritic spines with a calpain substrate exhibiting fluorescence resonance energy transfer. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[25] D. Storm,et al. Interactions between Neurogranin and Calmodulin in Vivo * , 1999, The Journal of Biological Chemistry.
[26] K. Blennow,et al. Identification of synaptic vesicle, pre‐ and postsynaptic proteins in human cerebrospinal fluid using liquid‐phase isoelectric focusing , 1999, Electrophoresis.
[27] K. Blennow,et al. Neurochemical Dissection of Synaptic Pathology in Alzheimer's Disease , 1998, International Psychogeriatrics.
[28] Gerendasy Dd,et al. RC3/neurogranin, a postsynaptic calpacitin for setting the response threshold to calcium influxes. , 1997 .
[29] A. Rhoads,et al. Sequence motifs for calmodulin recognition , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[30] J. Mallet,et al. Neurogranin is locally concentrated in rat cortical and hippocampal neurons , 1996, Brain Research.
[31] R. Nixon,et al. Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[32] D. Salmon,et al. Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.
[33] A. Porter,et al. Purification and characterization of human brain prolyl endopeptidase. , 1991, The Biochemical journal.
[34] Y. Ben-Ari,et al. Neurogranin: immunocytochemical localization of a brain-specific protein kinase C substrate , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[35] T. Nagatsu,et al. Post-proline cleaving enzyme in human cerebrospinal fluid from control patients and parkinsonian patients. , 1987, Biochemical medicine and metabolic biology.
[36] D. Mann,et al. A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease , 1987, Journal of the Neurological Sciences.
[37] D. Gerendasy,et al. RC3/neurogranin, a postsynaptic calpacitin for setting the response threshold to calcium influxes , 2007, Molecular Neurobiology.
[38] V. Fülöp,et al. Structure-function properties of prolyl oligopeptidase family enzymes , 2007, Cell Biochemistry and Biophysics.